CVS Health reports Q4 earnings on Feb. 12, with analysts watching cost trends, Medicare Advantage enrollment, and medical loss ratio impacts.

Founder of All Source Investment Management, explains tax strategies and private equity sources for wealth development ...

CVS has replaced its CEO, and is working to reassure investors. The stock has jumped more than 20% in the first weeks of 2025 ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Humana’s outlook isn’t great, but performance in the fourth quarter was a bit better than expected. Shares were up after the ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Greenwich LifeSciences (GLSI – Research Report) ...

Stock selection in the financials, consumer discretionary, communication services and information technology sectors drove ...

Three of the architects responsible for the GOP’s new Senate majority are launching a public affairs firm to try and ...